Search

everythinglearnresearchcommunity

for

Search:↓

Most adverse reactions to the treatment were mild, with nausea being the most common.

Some breast cancer chemotherapy can cause permanent hair loss.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Breast cancer patients need strong psychological support to improve their quality of life.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

Corticosteroids may not effectively control oxidative stress in alopecia areata, possibly leading to relapses.

Some cancer treatments can cause permanent hair loss.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Topical estrogen helps hair growth in menopausal women with no major side effects.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.